CIMAvax Vaccine and Nivolumab in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Study Number: 

I 286816

Phase: 
Early Phase
Trial categories: 
Early Phase Clinical Trial
Lung
Non-Small Cell Lung Cancer (NSCLC)
Immunotherapy
Antibody therapy
Checkpoint blockade
Principal Investigator: